0000899243-19-024071.txt : 20190923 0000899243-19-024071.hdr.sgml : 20190923 20190923200018 ACCESSION NUMBER: 0000899243-19-024071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190919 FILED AS OF DATE: 20190923 DATE AS OF CHANGE: 20190923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tompkins Tamara CENTRAL INDEX KEY: 0001501910 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38470 FILM NUMBER: 191109023 MAIL ADDRESS: STREET 1: C/O AMYRIS, INC. STREET 2: 5885 HOLLIS ST., SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unity Biotechnology, Inc. CENTRAL INDEX KEY: 0001463361 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264726035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (415) 328-5504 MAIL ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Cenexys, Inc. DATE OF NAME CHANGE: 20130703 FORMER COMPANY: FORMER CONFORMED NAME: Forge Inc DATE OF NAME CHANGE: 20090504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-19 0 0001463361 Unity Biotechnology, Inc. UBX 0001501910 Tompkins Tamara C/O UNITY BIOTECHNOLOGY, INC 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 0 1 0 0 See Remarks Common Stock, $0.0001 par value 21075 D Stock Option (Right to Buy) 3.40 2019-09-19 4 A 0 19068 0.00 A 2019-09-19 2027-07-26 Common Stock 19068 19068 D Includes Restricted Stock Units which vest over time measured from the grant date. On July 26, 2017, Reporting Person was granted an option exercisable for 76,271 shares. Twenty-five percent (25%) of the shares was subject to vesting pursuant to the achievement of a clinical development milestone; in this case proof of concept that treatment with a senolytic drug meaningfully ameliorates a human disease. On September 19, 2019, Issuer's Board of Directors determined that such milestone was achieved. Corporate Secretary and General Counsel /s/ Tamara L. Tompkins 2019-09-23